de Gramont, A <br/><br/>
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.  [electronic resource] 

 -  Cancer  Jan 1987 
 - 301-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19870115)59:2<301::aid-cncr2820590222>3.0.co;2-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Erythrocyte Indices<br/>Hodgkin Disease--blood<br/>Humans<br/>Leukemia, Lymphoid--etiology<br/>Mathematics<br/>Mechlorethamine--therapeutic use<br/>Prednisone--therapeutic use<br/>Procarbazine--therapeutic use<br/>Prognosis<br/>Risk<br/>Time Factors<br/>Vincristine--therapeutic use